Risperdal Breast Growth Lawsuits

Sponsored by Hissey-Kientz - Committed to protecting your legal rights.
Call us Toll Free at 866-275-4454 for a FREE Consultation
Help and information about Testosterone lawsuit issues.

Australian Therapeutic Goods Administration restricts Risperdal due to strokes

September 4th, 2015

Australia’s Therapeutic Goods Administration (the equivalent of the U.S. Food and Drug Administration) has restricted the use of Risperdal due to increased risks of strokes in patients. The TGA cited a study which found patients being treated with Risperdal for dementia other than Alzheimer’s were more than twice as likely to suffer from cerebrovascular events (strokes).

Some doctors have expressed increased concern over Risperdal side effects after several studies have linked the drug to various conditions, including gynecomastia in boys and male adolescents. Gynecomastia is the development of breast tissue, a condition that comes from increased levels of the hormone prolactin and often requires surgery to correct.

Risperdal manufacturer Janssen Pharmaceuticals along with parent company Johnson & Johnson currently face multiple Risperdal lawsuits alleging that the drug caused breast growth in young boys. The company has recently been ordered to pay millions to patients who developed breasts after being given the drug to treat bipolar disorder and symptoms of ADHD.


Contact Us Today for a Free Consultation.

I am currently represented by an attorney.
*Required fields